Neonatal thrombotic microangiopathy secondary to factor I variant with Hirschsprung disease
- 1 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Nephrology
- Vol. 34 (1), 241-245
- https://doi.org/10.1007/s40620-020-00766-5
Abstract
Neonatal thrombotic microangiopathy (TMA) is a rare and severe disease characterized by a triad of non-immune hemolytic anemia, thrombocytopenia, and organ dysfunction in neonates. We describe herein an early-term infant who underwent hemicolectomy at 4 days of age due to intestinal perforation. Following surgery, the patient had recurrent bouts of vomiting and abdominal distention, together with acute kidney injury, non-immune hemolytic anemia, and severe thrombocytopenia. Low complement levels raised the possibility of complement-mediated neonatal TMA. Finally, genetic tests identified a heterozygous mutation in the complement factor I gene. Anti-C5 monoclonal antibody therapy led to complete cessation of the hematological and renal manifestations, but symptoms of intestinal obstruction recurred. Intestinal biopsy demonstrated aganglionosis, compatible with Hirschsprung disease. This presentation is the first known case of neonatal complement-mediated TMA associated with Hirschsprung disease. Moreover, it highlights the importance of considering a diagnosis of TMA in cases of atypical neonatal infectious presentation.This publication has 19 references indexed in Scilit:
- An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathyClinical Kidney Journal, 2019
- Haemolytic uraemic syndromeThe Lancet, 2017
- Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies ConferenceKidney International, 2017
- An international consensus approach to the management of atypical hemolytic uremic syndrome in childrenPediatric Nephrology, 2015
- Anti-glomerular basement membrane glomerulonephritis and thrombotic microangiopathy in first degree relatives; a case reportBMC Nephrology, 2012
- Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristicsPediatric Nephrology, 2012
- Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical PhenotypeClinical Journal of the American Society of Nephrology, 2010
- aHUS caused by complement dysregulation: new therapies on the horizonPediatric Nephrology, 2010
- A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulationMolecular Immunology, 2007
- Heterozygous and Homozygous Factor H Deficiencies Associated with Hemolytic Uremic Syndrome or Membranoproliferative GlomerulonephritisJournal of the American Society of Nephrology, 2004